or
Remember me
Back
$ASEP.c recently published the results of a sepsis study completed by RTI Health Solutions. RTI’s study, contracted by $ASEP determines the market opportunity in the impact of early and accurate sepsis diagnosis. Details here: https://ca.finance.yahoo.com/news/asep-medical-holdings-inc-announces-120000639.html
Acc. to one of the study’s findings, "Overall, early and appropriate antibiotic treatment is associated with an absolute decrease of 7% in mortality and a reduction of length of stay in the hospital of 5.85 days. This results in a reduction in costs of $14,555 in patients with sepsis without organ dysfunction, $17,134 in patients with sepsis with organ dysfunction, and $19,300 in patients with septic shock.” This could be a genuine game changer in the healthcare market and change the lives of so many.
td, $ASEP.c @ $0.40 MC $22.45 M
Receive investor kits and email updates from Stockhouse and directly from these companies.
